Amphenol (APH)
(Delayed Data from NYSE)
$136.40 USD
+1.83 (1.36%)
Updated May 23, 2024 04:00 PM ET
After-Market: $136.42 +0.02 (0.01%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Price, Consensus and EPS Surprise
APH 136.40 +1.83(1.36%)
Will APH be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for APH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APH
Has Amphenol (APH) Outpaced Other Computer and Technology Stocks This Year?
Carlisle (CSL) Divests Interconnect Technologies Business
APH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's How Much a $1000 Investment in Amphenol Made 10 Years Ago Would Be Worth Today
Why Amphenol (APH) is a Top Momentum Stock for the Long-Term
Why Amphenol (APH) is a Top Momentum Stock for the Long-Term
Other News for APH
Alliance Pharma Shareholding Structure Alters
Alliance Pharma Wins Appeal, Overturns CMA Fine
Apple foldable MacBooks could ship 1M units in 2026: analyst
Amphenol put volume heavy and directionally bearish
Amphenol’s Growth and Investor Appeal Bolstered by CIT Acquisition and Stock Split: Buy Rating Affirmed